Clinton targets Valeant price hikes in campaign appearance

ReutersNewsPublished: January 28, 20166 views
Published: January 28, 2016

Shares of Valeant Pharmaceuticals International fall after Hillary Clinton posted a blog detailing exorbitant price hikes for a migraine drug made by the company. Rough Cut (No reporter narration)

Be the first to suggest a tag